These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


150 related items for PubMed ID: 3102631

  • 1. Comparative efficacy of ciprofloxacin, azlocillin, and tobramycin alone and in combination in experimental Pseudomonas sepsis.
    Johnson M, Miniter P, Andriole VT.
    J Infect Dis; 1987 Apr; 155(4):783-8. PubMed ID: 3102631
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of ciprofloxacin alone and in combination with azlocillin in experimental endocarditis due to Pseudomonas aeruginosa.
    Thauvin C, Lecomte F, Le Boete I, Grise G, Lemeland JF.
    Infection; 1989 Apr; 17(1):31-4. PubMed ID: 2493429
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model.
    Bamberger DM, Peterson LR, Gerding DN, Moody JA, Fasching CE.
    J Antimicrob Chemother; 1986 Jul; 18(1):51-63. PubMed ID: 3093445
    [Abstract] [Full Text] [Related]

  • 5. Comparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis.
    Strunk RW, Gratz JC, Maserati R, Scheld WM.
    Antimicrob Agents Chemother; 1985 Sep; 28(3):428-32. PubMed ID: 2934021
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ciprofloxacin in the treatment of Pseudomonas infection in cystic fibrosis patients.
    Rubio TT, Shapiro C.
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():147-52. PubMed ID: 3100490
    [Abstract] [Full Text] [Related]

  • 9. Ability of azlocillin and tobramycin in combination to delay or prevent resistance development in Pseudomonas aeruginosa.
    Wu YL, Scott EM, Po AL, Tariq VN.
    J Antimicrob Chemother; 1999 Sep; 44(3):389-92. PubMed ID: 10511408
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunoglobulin G: potentiation of tobramycin and azlocillin in the treatment of Pseudomonas aeruginosa sepsis in neutropenic mice and neutralization of exotoxin A in vivo.
    Collins MS, Tsay GC, Hector RF, Roby RE, Dorsey JH.
    Rev Infect Dis; 1986 Sep; 8 Suppl 4():S420-5. PubMed ID: 3092309
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combination therapy with ciprofloxacin plus azlocillin against Pseudomonas aeruginosa: effect of simultaneous versus staggered administration in an in vitro model of infection.
    Dudley MN, Blaser J, Gilbert D, Mayer KH, Zinner SH.
    J Infect Dis; 1991 Sep; 164(3):499-506. PubMed ID: 1908000
    [Abstract] [Full Text] [Related]

  • 15. Use of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections.
    Follath F, Bindschedler M, Wenk M, Frei R, Stalder H, Reber H.
    Eur J Clin Microbiol; 1986 Apr; 5(2):236-40. PubMed ID: 2941289
    [Abstract] [Full Text] [Related]

  • 16. In vivo and in vitro activity of ciprofloxacin plus azlocillin against 12 streptococcal isolates in a neutropenic site model.
    Peterson LR, Moody JA, Fasching CE, Gerding DN.
    Diagn Microbiol Infect Dis; 1987 Jun; 7(2):127-36. PubMed ID: 3115671
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
    Møller NE, Eriksen KR, Feddersen C, Flensborg EW, Høiby N, Norn S, Rosendal K, Schiøtz PO, Skov PS.
    Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561
    [Abstract] [Full Text] [Related]

  • 20. [Ciprofloxacin in combination with other antimicrobial substances].
    Shah PM, Mellinghoff D, Stille W.
    Arzneimittelforschung; 1988 Mar; 38(3):411-5. PubMed ID: 3164186
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.